Skip to main content

Table 2 Process evaluation

From: Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial

Element

Questions

Measures

Data sources/tools

Reach

1) What % of eligible patients consented to receive the intervention?

1) Recruitment rates

1) Enrolment tracking sheets

2) Do those that consent differ significantly from those that do not?

2) Socio-demographics of all eligible participants stratified by consent/refused

2) Enrolment tracking sheets

Effectiveness

What is the effect of the intervention on patient outcomes?

Main study outcomes comparing interventions and control

Study datasets

Adoption

1) What are the main barriers/facilitators to adopting the intervention?

1) Perceptions of research/clinic staff, facility management, National Health Laboratory Service (NHLS) & National Dept. of Health (NDoH)

1) Staff observational logs and post-intervention interviews

2) What systems need to be in place for the health system to adopt intervention?

 

2) Post-intervention interviews clinic and national stakeholders

Implementation

1) What does the intervention cost?

1) Cost/Cost-effectiveness data

1) Study datasets

2) What support and tools are needed for consistent delivery of intervention?

2) Perceptions of study and clinic staff, NHLS and NDoH

2) Post-intervention interviews w/ clinic and national stakeholders

Maintenance

1) What resources will be needed for the intervention to be sustainable?

1) Perceptions of research staff, facility managers, NHLS and NDoH

1) Research staff observation logs, post-intervention interviews

2) What adaptions are needed to integrate intervention into current practices?

 

2) Post-intervention interviews clinic and national stakeholders